ERYTECH receives the EnterNext Tech 40 Label Post author:admERY Post published:April 28, 2015 Post category:Newsroom ERYTECH has received the EnterNext Tech 40 Label and announces its inclusion in the Tech 40 index. You Might Also Like ERYTECH Enters Into Strategic Supply Partnership with the German Red Cross Blood Donor Service February 20, 2020 ERYTECH Granted U.S. FDA Fast Track Designation for eryaspase in Second-Line Pancreatic Cancer April 28, 2020 ERYTECH reports additional positive Phase III results from clinical study with eryaspase/GRASPA® in Acute Lymphoblastic Leukemia December 8, 2014
ERYTECH Enters Into Strategic Supply Partnership with the German Red Cross Blood Donor Service February 20, 2020
ERYTECH Granted U.S. FDA Fast Track Designation for eryaspase in Second-Line Pancreatic Cancer April 28, 2020
ERYTECH reports additional positive Phase III results from clinical study with eryaspase/GRASPA® in Acute Lymphoblastic Leukemia December 8, 2014
